Welcome to Burg Simpson Eldredge Hersh and Jardine's site, please upgrade your Flash Plugin and enable JavaScript.
Hot Topics
Explosion Accidents:
"Pooch alive after
Breck blast"
– Denver Post
"Baxter to Proceed with Recall of Remaining Heparin Sodium Vial Products"
– FDA
Yamaha Rhino ATV Rollover Accidents
and Injuries
"UBS Hit by
Another Lawsuit"
– Ben Levinsohn, BusinessWeek
"Hedge Funds
Frozen Shut"
– Matthew Goldstein, BusinessWeek
"MRI Contrast Can Cause Disease – Gadolinium Blamed
For Problems"
– Dayle Cedars
7News, Denver, CO
Results
$690,000,000
Global settlement with Eli Lilly and Company regarding its product Zyprexa negotiated by a plaintiffs' attorney group including members of Burg Simpson.
$5,800,000
Hines, et al, vs. Cody Gas Company, et al: verdict for injuries, damages, losses from gas explosion.
CLICK HERE FOR MORE INFORMATION
Our Offices
40 Inverness Drive East
Denver, CO 80112
Phone: 303.792.5595
Fax: 303.708.0527
WYOMING OFFICE
Phone: 307.527.7891
Fax: 307.527.7897
OHIO OFFICE
Phone: 513.852.5600
Fax: 513.852.5611
DALLAS OFFICE
Phone: 972.934.1313
Fax: 972.231.3983
ARIZONA OFFICE
Phone: 602.508.6040
WASHINGTON D.C. OFFICE
Phone: 202.544.7600
Litigation Updates
Ortho Evra Warning Label Recognizes Higher Blood Clot Risk
It was announced yesterday that the warning label on the Ortho Evra birth control patch has been updated to alert women that the risk of blood clots in the legs and lungs may be higher for users of the patch as opposed to those women that use the pill. The FDA ordered the updated warning label to reflect the results of a study that found that women using the patch faced twice the risk of developing blood clots than those women taking the pill.
Johnson & Johnson also announced a change in the Ortho Evra warning label in November 2005 to disclose that women who use the Patch are exposed to approximately 60% more estrogen than those using an oral hormonal contraceptive. This increased exposure to estrogen makes the Patch comparable to the high-dose estrogen forms of the Pill that the FDA required to be removed from the market in 1988.
The Ortho Evra birth control patch became commercially available in 2002 and has been prescribed to more than 4 million women since its launch.
The U.S. District Court for the Northern District of Ohio has appointed Michael Burg and Janet Abaray of Burg Simpson as lead counsel for all cases in Federal Court pending in the national Multi-District Litigation.
If you are interested in a co-counsel relationship with Burg Simpson on Ortho Evra cases you acquire, please contact Seth A. Katz or Kerry N. Jardine.
